Vis enkel innførsel

dc.contributor.authorChristensen, Ingrid Egeland
dc.contributor.authorJyssum, Ingrid
dc.contributor.authorTveter, Anne Therese
dc.contributor.authorSexton, Joseph
dc.contributor.authorTran, Trung
dc.contributor.authorMjaaland, Siri
dc.contributor.authorKro, Grete Anette Birkeland
dc.contributor.authorKvien, Tore Kristian
dc.contributor.authorWarren, David
dc.contributor.authorJahnsen, Jørgen
dc.contributor.authorMunthe, Ludvig Andre
dc.contributor.authorHaavardsholm, Espen A.
dc.contributor.authorVaage, John T.
dc.contributor.authorGrødeland, Gunnveig
dc.contributor.authorLund-Johansen, Fridtjof
dc.contributor.authorJørgensen, Kristin Kaasen
dc.contributor.authorSyversen, Silje Watterdal
dc.contributor.authorGoll, Guro Løvik
dc.contributor.authorProvan, Sella Aarrestad
dc.date.accessioned2022-11-28T07:30:55Z
dc.date.available2022-11-28T07:30:55Z
dc.date.created2022-11-16T15:13:48Z
dc.date.issued2022
dc.identifier.citationBMC Medicine. 2022, 20 (1), 1-13.
dc.identifier.issn1741-7015
dc.identifier.urihttps://hdl.handle.net/11250/3034330
dc.language.isoeng
dc.titleThe persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls—a prospective cohort study
dc.title.alternativeThe persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls—a prospective cohort study
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber1-13
dc.source.volume20
dc.source.journalBMC Medicine
dc.source.issue1
dc.identifier.doi10.1186/s12916-022-02587-8
dc.identifier.cristin2075057
dc.relation.projectNorges forskningsråd: 328657
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel